feed,title,long_url,short_url
Investors,Alnylam Skyrockets After Hitting A 'Best-Case Scenario' For Heart Drug,https://www.investors.com/news/technology/alnylam-stock-attr-amyloidosis-cardiomyopathy-vutrisiran-pfizer-vyndamax/,https://da.gd/JxSj0q
